Problems with streptokinase therapy in acute pulmonary embolism.

[1]  V. Gurewich,et al.  Detection of intravascular coagulation by a serial-dilution protamine sulfate test. , 1971, Annals of internal medicine.

[2]  J. Hirsh,et al.  Evaluation of a standard dosage schedule with streptokinase. , 1970, Blood.

[3]  D. Triantaphyllopoulos,et al.  Increased Prothrombin Conversion: A New Activity of Lysed Fibrinogen * , 1970, British journal of haematology.

[4]  D. Thomas,et al.  Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. , 1970, The Journal of laboratory and clinical medicine.

[5]  A. J. Johnson,et al.  Assay Methods and Standard Preparations for Plasmin, Plasminogen and Urokinase in Purified Systems, 1967-1968 , 1969, Thrombosis and Haemostasis.

[6]  J. Hirsh,et al.  Streptokinase Therapy in Acute Major Pulmonary Embolism: Effectiveness and Problems , 1968, British medical journal.

[7]  D. Negus,et al.  125I‐labelled fibrinogen in the diagnosis of deep‐vein thrombosis and its correlation with phlebography , 1968, The British journal of surgery.

[8]  V. Kakkar,et al.  The detection of venous thrombosis of the legs using 125I‐labelled fibrinogen , 1968, The British journal of surgery.

[9]  K. Robbins,et al.  Isolation and characterization of bovine plasminogen activator from a human plasminogen-streptokinase mixture. , 1967, The Journal of biological chemistry.

[10]  P. O. Ganrot,et al.  Plasmin, Plasmin Inhibitors and Degradation Products of Fibrinogen in Human Serum during and after Intravenous Infusion of Streptokinase , 1967 .

[11]  Jeffrey M. Schwartz,et al.  Appendectomy in hemophilia with the use of cryoprecipitated human factor 8 to control bleeding. , 1966, JAMA.

[12]  F. Praetorius,et al.  Thrombolytic therapy of recent myocardial infarction. I. Introduction, plan of trial, general clinical results. , 1966, German medical monthly.

[13]  A. Amery,et al.  Thrombolytic Therapy with Streptokinase Using a Standard Dosage Scheme , 1966, British medical journal.

[14]  D. Ogston,et al.  The Plasminogen Content of Thrombi , 1966, Thrombosis and Haemostasis.

[15]  A. Fletcher,et al.  THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. , 1965, The Journal of laboratory and clinical medicine.

[16]  C. D. Wit,et al.  The Role of Plasminogen in Fibrinolysis * , 1962 .

[17]  P. Fantl,et al.  Plasminogen Activity of Plasma and Serum , 1962, Science.

[18]  J. B. Fishman,et al.  Improved procedure for the isolation of human plasminogen. , 1961, The Journal of biological chemistry.

[19]  A. Fletcher,et al.  Thrombolytic Therapy: Basic and Therapeutic Considerations , 1961 .

[20]  S. Sherry,et al.  A Comparison of the Fibrinolytic and Fibrinogenolytic Effects of Plasminogen Activators and Proteolytic Enzymes in Plasma , 1961, Thrombosis and Haemostasis.

[21]  A. Johnson,et al.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. , 1959, The Journal of clinical investigation.

[22]  A. Fletcher,et al.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects. , 1959, The Journal of clinical investigation.

[23]  A. Fletcher,et al.  The mechanism of clot dissolution by plasmin. , 1959, The Journal of clinical investigation.

[24]  M. Lassen.  Heat denaturation of plasminogen in the fibrin plate method. , 1953, Acta physiologica Scandinavica.

[25]  T. Astrup,et al.  The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.